,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2014-12-21 09:42:00,"The $1,000 human genome took a giant leap closer to reality when Illuminalaunched the HiSeq X Ten Sequencing System in early 2014.",0.47316309809684753,0.012801420874893665,0.5140355229377747,neutral,0.46036168932914734
1,2014-12-21 09:42:00,"Sequencing your genome costs over five times that amount using any other system, and had cost nearly 10 times that amount as recently as 2007.",0.18443769216537476,0.02812999114394188,0.7874323129653931,neutral,0.15630769729614258
2,2014-12-21 09:42:00,"In other words, the company is easily setting the pace for the next-generation sequencing market -- and causing prices to drop precipitously every few years.",0.35491853952407837,0.10636488348245621,0.5387165546417236,neutral,0.24855366349220276
3,2014-12-21 09:42:00,The cost of sequencing a full human genome as estimated by the National Human Genome Research Institute.,0.03126399219036102,0.029724255204200745,0.9390117526054382,neutral,0.0015397369861602783
4,2014-12-21 09:42:00,Costs do not account for Illumina's latest system.,0.00983754638582468,0.08455254882574081,0.9056098461151123,neutral,-0.07471500337123871
5,2014-12-21 09:42:00,Image source: Ben Moore/ Wikimedia Commons .,0.02682647481560707,0.024384843185544014,0.9487887024879456,neutral,0.002441631630063057
6,2014-12-21 09:42:00,"While Illumina specializes in data quantity for full-length genomes, the PacBio RS II from Pacific Biosciences allows researchers to zoom into specific regions of a sequence with exceptional accuracy.",0.18462425470352173,0.007654898799955845,0.8077208399772644,neutral,0.17696934938430786
7,2014-12-21 09:42:00,The two systems are often used together to provide a full range of capabilities.,0.2961422801017761,0.016059892252087593,0.6877978444099426,neutral,0.2800823748111725
8,2014-12-21 09:42:00,"That bodes well for genomics researchers and pharmaceutical companies, but the appetite for larger volumes of high quality data will trickle down to consumers in the form of even lower-cost gene sequencing.",0.7250035405158997,0.01630869135260582,0.25868770480155945,positive,0.7086948752403259
9,2014-12-21 09:42:00,"If sequencing costs fall to several hundred dollars (or less) by the end of the decade, everyday life will look a little different than it does today.",0.04968199133872986,0.11160964518785477,0.8387083411216736,neutral,-0.06192765384912491
10,2014-12-21 09:42:00,"Let's take a look at five habits you may adopt, from the time you're born to the day you retire, when low-cost genome sequencing becomes commonplace.",0.040924202650785446,0.011755094863474369,0.9473206996917725,neutral,0.02916910871863365
11,2014-12-21 09:42:00,1.,0.029014499858021736,0.015284966677427292,0.9557005167007446,neutral,0.013729533180594444
12,2014-12-21 09:42:00,"The habit of screening the full genomes of newborns

Today, all babies born in a hospital in the United States are screened for various diseases before they're sent home.",0.03119111992418766,0.021363137289881706,0.9474457502365112,neutral,0.009827982634305954
13,2014-12-21 09:42:00,"Although the conditions tested vary slightly from state to state , current tests send blood samples drawn from a baby's heel to the hospital's lab for testing.",0.01055638026446104,0.016341647133231163,0.9731019735336304,neutral,-0.0057852668687701225
14,2014-12-21 09:42:00,"While considered one of the most successful public health programs on the planet, today's newborn genetic screening tests only look for several dozen health conditions.",0.29694029688835144,0.010854379273951054,0.6922053098678589,neutral,0.28608590364456177
15,2014-12-21 09:42:00,Full-genome sequencing could alleviate diagnostic bottlenecks inherent to current blood tests and greatly expand the usefulness of newborn sequencing.,0.9179102182388306,0.015289000235497952,0.06680077314376831,positive,0.9026212096214294
16,2014-12-21 09:42:00,"By allowing parents to peer into the full genome of their newborn, doctors could monitor individuals genetically shown to be at increased risk of disease or even begin preventative or early treatment.",0.10356280207633972,0.016114648431539536,0.8803225755691528,neutral,0.08744814991950989
17,2014-12-21 09:42:00,"Most parents would welcome the insights, according to a study recently published in Genetics in Medicine .",0.24388252198696136,0.0206964910030365,0.7354210019111633,neutral,0.22318603098392487
18,2014-12-21 09:42:00,"Doctors approached 514 parents each within 48 hours of their child's birth, explained the genome's impact on human health, and asked if they'd be interested in newborn genomic screening.",0.18073470890522003,0.017909305170178413,0.8013559579849243,neutral,0.16282540559768677
19,2014-12-21 09:42:00,"Nearly 83% expressed some level of interest in the tests if they were available, which could become routine in the next decade.",0.3059806525707245,0.010041726753115654,0.6839776039123535,neutral,0.2959389388561249
20,2014-12-21 09:42:00,Sequencing wouldn't stop once you left the hospital after being born.,0.11315440386533737,0.1656060814857483,0.7212395071983337,neutral,-0.05245167762041092
21,2014-12-21 09:42:00,"While you may be born with a unique genetic code, your environment plays a critical role in determining which genes are expressed and silenced.",0.05119360610842705,0.007119447458535433,0.9416869878768921,neutral,0.0440741591155529
22,2014-12-21 09:42:00,"Factors such as nutrient intake, stress levels, exposure to specific chemicals, altitude, physical activity, and many more can turn genes on and off throughout your lifetime.",0.030471542850136757,0.04271561652421951,0.9268128275871277,neutral,-0.012244073674082756
23,2014-12-21 09:42:00,"If sequencing costs become low enough, then you might undergo routine genetic screenings every few years, at your annual physical, or even every time you become ill to track changes in your genome over time.",0.02507430501282215,0.02050943858921528,0.9544162750244141,neutral,0.0045648664236068726
24,2014-12-21 09:42:00,"Similar to newborn genomic screening, routine genomic checkups could detect diseases at the earliest stages of development, which, if used across a sizable population, would have a profound effect on our approach to healthcare by allowing more preventative treatments.",0.26175442337989807,0.009520146995782852,0.7287254333496094,neutral,0.2522342801094055
25,2014-12-21 09:42:00,3.,0.02229742705821991,0.014547630213201046,0.9631549715995789,neutral,0.007749796845018864
26,2014-12-21 09:42:00,"The habit of buying products optimized for your genes

You shouldn't have to fight back anxiety every time you peer into your genome for fear of being at an elevated risk for disease.",0.10328008979558945,0.07712361216545105,0.8195962905883789,neutral,0.026156477630138397
27,2014-12-21 09:42:00,"Luckily, some of your results will have nothing to do with health at all.",0.017797784879803658,0.015223821625113487,0.9669783711433411,neutral,0.0025739632546901703
28,2014-12-21 09:42:00,Not convinced that reading your genome sequence could ever be fun?,0.10649176687002182,0.12371190637350082,0.7697963714599609,neutral,-0.017220139503479004
29,2014-12-21 09:42:00,"Well, specific results could affect the way you shop.",0.013471219688653946,0.016485728323459625,0.9700430035591125,neutral,-0.0030145086348056793
30,2014-12-21 09:42:00,"Although likely unknown to most consumers and investors, personal care behemoth Procter & Gamble has established itself as a genomics leader.",0.8464407324790955,0.016848862171173096,0.13671036064624786,positive,0.8295918703079224
31,2014-12-21 09:42:00,The company sequenced the fungus responsible for most human dandruff to develop more effective shampoos under its Head & Shoulders brand -- and patented the microbe's genes in the process.,0.422029972076416,0.011263073422014713,0.5667069554328918,neutral,0.4107668995857239
32,2014-12-21 09:42:00,Genomics research has also allowed the company to develop premium diaper lines that are less likely to cause skin rashes and study how specific cosmetic agents affect skin cells of all ages and profiles.,0.596729576587677,0.009977716021239758,0.39329278469085693,positive,0.5867518782615662
33,2014-12-21 09:42:00,"While having a treasure trove of genomics data is useful for internal development, Procter & Gamble is actively preparing for the day that consumers have easy access to cheap genome sequencing, too.",0.43495824933052063,0.009945984929800034,0.5550957918167114,neutral,0.4250122606754303
34,2014-12-21 09:42:00,Why?,0.08602532744407654,0.06414811313152313,0.8498265147209167,neutral,0.021877214312553406
35,2014-12-21 09:42:00,The company could develop personalized personal care products marketed to individuals with specific genetic traits.,0.1115139052271843,0.004687217529863119,0.8837988972663879,neutral,0.10682668536901474
36,2014-12-21 09:42:00,Here's a fictional example: Let's say you always get dry skin after washing your face with certain products.,0.04360008239746094,0.06629981845617294,0.8901001214981079,neutral,-0.022699736058712006
37,2014-12-21 09:42:00,Your latest sequencing results tell you that you have one of two possible genes that determine how your skin retains moisture.,0.05888543277978897,0.008106530643999577,0.9330080151557922,neutral,0.05077890306711197
38,2014-12-21 09:42:00,"Procter & Gamble could market two face wash products -- one tailored for each genetic outcome -- you could buy the one that matches your gene, and enjoy more moisturized skin.",0.08784694969654083,0.005686469841748476,0.9064666032791138,neutral,0.08216048032045364
39,2014-12-21 09:42:00,"Shopping, product labeling, and advertising would never be the same.",0.053788188844919205,0.07687649875879288,0.8693353533744812,neutral,-0.023088309913873672
40,2014-12-21 09:42:00,"If you can have personalized face wash, then why not medicine, too?",0.048674143850803375,0.01167390402406454,0.9396519064903259,neutral,0.03700023889541626
41,2014-12-21 09:42:00,"While the media often talks about personalized medicine, the ability to quickly and cheaply sequence a patient's genome could make it a reality.",0.24161335825920105,0.01186708640307188,0.7465195655822754,neutral,0.2297462671995163
42,2014-12-21 09:42:00,"There are many hurdles to overcome, but viable stepping stones are already within reach.",0.7015524506568909,0.028575757518410683,0.2698717713356018,positive,0.6729766726493835
43,2014-12-21 09:42:00,Take cancer for instance.,0.06468740850687027,0.04252466931939125,0.8927879333496094,neutral,0.02216273918747902
44,2014-12-21 09:42:00,"Doctors could sequence a cancerous tissue sample, which contains a genome that varies from that of the patient, to determine where the cancer originated and if specific mutations have occurred.",0.01969960704445839,0.015276319347321987,0.9650241136550903,neutral,0.004423287697136402
45,2014-12-21 09:42:00,The information could then be used to develop a personalized treatment plan to maximize drug response and potentially reduce side effects.,0.3054649233818054,0.0070768482983112335,0.6874582171440125,neutral,0.2983880639076233
46,2014-12-21 09:42:00,Sequencing could even be repeated after each therapy session to track mutations and adjust the treatment plan.,0.04093960300087929,0.009242702275514603,0.9498177766799927,neutral,0.031696900725364685
47,2014-12-21 09:42:00,Good news: cancer genome sequencing is actually being used today.,0.2846028506755829,0.00852347444742918,0.7068736553192139,neutral,0.276079386472702
48,2014-12-21 09:42:00,"In fact, two drugs (Xalkori from Pfizer and Zykadia from Novartis ) have already been approved by the U.S. Food and Drug Administration to treat a specific mutation observed in lung cancer.",0.6899996995925903,0.016583602875471115,0.29341667890548706,positive,0.6734160780906677
49,2014-12-21 09:42:00,But the potential is much greater.,0.7074217200279236,0.017027519643306732,0.2755507826805115,positive,0.6903942227363586
50,2014-12-21 09:42:00,"Since cancer is a disease of an individual's cells, approaching drug development with one-size-fits-all clinical trials may never produce cures.",0.07938449084758759,0.1591453105211258,0.7614701390266418,neutral,-0.07976081967353821
51,2014-12-21 09:42:00,"There's a very long way to go in understanding which mutations respond to which types of drugs, but cancer genome sequencing offers one promising avenue.",0.2462974637746811,0.00843330379575491,0.745269238948822,neutral,0.2378641664981842
52,2014-12-21 09:42:00,5.,0.023618461564183235,0.016584821045398712,0.9597967267036438,neutral,0.007033640518784523
53,2014-12-21 09:42:00,"The habit of sequencing... everything

Advances in sequencing the 6 billion base pairs in the human genome will trickle down (and up) to technologies aimed at sequencing other organisms and living things.",0.16556650400161743,0.006513107102364302,0.8279204368591309,neutral,0.15905340015888214
54,2014-12-21 09:42:00,We could find new drug candidates by sequencing rare plants and discover genes with industrial importance to create the ultimate microbial factories for manufacturing biobased chemicals.,0.37234190106391907,0.009623004123568535,0.6180351376533508,neutral,0.3627189099788666
55,2014-12-21 09:42:00,"We could even equip the next Mars or asteroid rover with a tiny sequencer, beam extraterrestrial genomes back to Earth, and reconstruct them piece by piece by synthesizing DNA (sequencing is ""reading"" DNA, synthesis is ""writing"" DNA).",0.07045435160398483,0.0074434783309698105,0.9221022129058838,neutral,0.06301087141036987
56,2014-12-21 09:42:00,Sound crazy?,0.1254449486732483,0.13151590526103973,0.7430391907691956,neutral,-0.006070956587791443
57,2014-12-21 09:42:00,"Don't tell that to J. Craig Venter and Synthetic Genomics, which, with the help of DARPA, are working on just such a machine .",0.055481161922216415,0.013154820539057255,0.9313640594482422,neutral,0.042326342314481735
58,2014-12-21 09:42:00,"That may not affect you directly, but your household may one day own a similar device.",0.026092225685715675,0.011940754018723965,0.9619669914245605,neutral,0.01415147166699171
59,2014-12-21 09:42:00,"Although years into the future, a Digital Biological Converter could allow you to upload swabs of a sick family member's infection, receive recommended treatment options from the Centers for Disease Control over a secure connection, download them, and ""print"" a therapeutic.",0.09256461262702942,0.018017536029219627,0.8894178867340088,neutral,0.07454707473516464
60,2014-12-21 09:42:00,No trip to the doctor or pharmacy required.,0.017325155436992645,0.012520432472229004,0.9701544046401978,neutral,0.004804722964763641
61,2014-12-21 09:42:00,What does it mean for investors?,0.03784635663032532,0.0232339296489954,0.9389196634292603,neutral,0.014612426981329918
62,2014-12-21 09:42:00,"Low-cost genome sequencing could extend many benefits to society ranging from discovering, monitoring, and treating disease to making shopping personalized.",0.4739782214164734,0.011189230717718601,0.5148324966430664,neutral,0.46278899908065796
63,2014-12-21 09:42:00,"While investments have historically been confined to a limited number of players who have acted as gatekeepers for related technologies (Illumina has returned 4,620% in the last decade), cheaper sequencing will broaden access and allow multiple companies, some of which you may never have considered (i.e.",0.4518641233444214,0.008675191551446915,0.5394607186317444,neutral,0.44318893551826477
64,2014-12-21 09:42:00,"Procter & Gamble), to share in the benefits.",0.15725143253803253,0.006610661279410124,0.8361378908157349,neutral,0.15064077079296112
65,2014-12-21 09:42:00,"1 great healthcare stock to buy for 2015 and beyond

Healthcare stocks soared in 2014, and 2015 is shaping up to be another great year for stocks.",0.8619537353515625,0.018001774325966835,0.12004446983337402,positive,0.843951940536499
66,2014-12-21 09:42:00,"But if you want to make sure you're buying one of the best healthcare stocks, you need to know where to start.",0.18774770200252533,0.009757769294083118,0.8024945259094238,neutral,0.1779899299144745
67,2014-12-21 09:42:00,That's why The Motley Fool's chief investment officer just published a brand-new research report that reveals his top stock for the year ahead.,0.13670983910560608,0.02149822935461998,0.8417919278144836,neutral,0.1152116060256958
68,2014-12-21 09:42:00,To get the full story on this year's stock -- completely free -- simply click here .,0.020147698000073433,0.011273055337369442,0.9685792326927185,neutral,0.008874642662703991
69,2014-12-21 09:42:00,The article 5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing originally appeared on Fool.com.,0.027619777247309685,0.03657848387956619,0.9358017444610596,neutral,-0.008958706632256508
70,2014-12-21 09:42:00,"Maxx Chatsko has no position in any stocks mentioned.Check out hispersonal portfolio,CAPS page,previous writing for The Motley Fool, and follow him on Twitter to keep up with developments in the synthetic biology field.The Motley Fool recommends Illumina, Pacific Biosciences of California, and Procter & Gamble.",0.020759638398885727,0.018340926617383957,0.9608994722366333,neutral,0.00241871178150177
71,2014-12-21 09:42:00,Try any of our Foolish newsletter services free for 30 days .,0.02325451746582985,0.013860778883099556,0.9628846645355225,neutral,0.009393738582730293
72,2014-12-21 09:42:00,"We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.",0.7942618727684021,0.015105843544006348,0.19063223898410797,positive,0.7791560292243958
73,2014-12-21 09:42:00,The Motley Fool has a disclosure policy .,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
74,2014-12-21 09:42:00,"Copyright Â© 1995 - 2014 The Motley Fool, LLC.",0.02662895992398262,0.023084871470928192,0.9502861499786377,neutral,0.003544088453054428
75,2014-12-21 09:42:00,All rights reserved.,0.01556148286908865,0.01622452400624752,0.9682139754295349,neutral,-0.0006630411371588707
76,2014-12-21 09:42:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
77,2014-12-21 09:42:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
